Brain Cancer, Brain Tumors: By The Numbers - NBC4 Washington

Brain Cancer, Brain Tumors: By The Numbers



    Brain Cancer, Brain Tumors: By The Numbers

    Brain Tumors By The Numbers: information provided by

    Quick Facts

    • 688,096 Americans are living with a brain tumor.
      • 550,042 tumors are benign.
      • 138,054 tumors are malignant.
    • An estimated 68,470 people will receive primary brain tumor diagnoses this year.
      • 45,300 will be benign.
      • 23,180 will be malignant.
        • Male: 55.2%
        • Female: 44.8%
    • The average survival rate for all malignant brain tumor patients is only 34.2%.
      • Male: 32.6%
      • Female: 44.8%
      • For the most common form of primary malignant brain tumors, glioblastoma multiforme, the five-year relative survival rate is only approximately 5% - 10%, with most patients dying within 15 months.
    • An estimated 13,770 people will die from malignant brain tumors (brain cancer) this year.

    Brain Tumors in Adults

    • The most prevalent brain tumor types in adults:
      • Gliomas, such as glioblastoma multiforme, ependymomas, astrocytomas, and oligodendrogliomas
      • Meningiomas

    Brain Tumors in Children

    • An estimated 28,000 children in the U.S. are living with a brain tumor.
    • An estimated 4,620 new cases of childhood and adolescent primary malignant and nonmalignant brain and CNS tumors are expected to be diagnosed in 2015.
    • Pediatric brain tumors are the most prevalent form of childhood cancer in kids under 19.
    • The average survival rate for all children with malignant brain tumors is 66%.
    • Brain tumors are the leading cause of cancer-related deaths in children under 14, and the second leading cause of cancer-related deaths in children and young adults under 20.
    • It is estimated that, in 2009, a total of 47,631.5 years of potential life were lost due to
    • brain tumors in children 0-19 years old.
    • The most prevalent brain tumor types in children:
      • Astrocytoma
      • Medulloblastoma
      • Ependymoma

    Additional Facts

    • More than any other cancer, brain tumors can have lasting and life-altering physical, cognitive, and psychological impacts on a patient’s life.
    • This means malignant brain tumors can often be described as equal parts neurological disease and deadly cancer.
    • Even benign brain tumors can be deadly if they interfere with portions of the brain
      responsible for vital bodily functions.
    • There are more than 120 different types of brain tumors, many with their own multitude
      of subtypes.
    • Despite the amount of brain tumors, and their devastating prognosis, there have only
      been four (4) FDA approved drugs to treat brain tumors.
      • For many tumor types, surgery and radiation remain the standard of care.
      • There has never been a drug developed and approved specifically for pediatric brain tumors.
      • The four approved therapies for brain tumors have provided only incremental improvements to patient survival, and mortality rates remain little changed over the past 30 years.
    • Between 1998 and 2014, there were 78 investigational brain tumor drugs that entered
      the clinical trial evaluation process. 75 failed, and only three (3) were approved (one
      conditionally). That is a 25:1 failure ratio in developing new brain tumor treatments over
      the past two decades.
    • Brain tumors have the highest per-patient initial cost of care for any cancer group, with
      an annualized mean net costs of care in 2010 US dollars at well over $100,000.
    • In addition to primary brain tumors, each year in the United States and estimated
      100,000 – 170,000 individual will be diagnosed with a secondary, or metastatic, brain
      • Five to 25 percent of cancer patients will develop metastases in the brain.
      • Many different cancer types often metastasize to the brain, including:
        • Breast cancer
        • Kidney cancer
        • Leukemia
        • Lung cancer
        • Lymphoma
        • Melanoma (where nearly 50% of cases will metastasize to the brain)

    Information provided by